Acute Investment Advisory’s Vanguard Mid-Cap Growth ETF VOT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-5,437
Closed -$1.38M 66
2021
Q4
$1.38M Buy
+5,437
New +$1.37M 1.01% 31

Other funds holding VOT

Acute Investment Advisory's VOT Position: Q1 2022 in Review

Acute Investment Advisory sold out of Vanguard Mid-Cap Growth ETF (VOT) in Q1 2022, closing a stake of 5,437 shares — an estimated $1.38M sold.

Acute Investment Advisory first reported a position in VOT in Q4 2021 and held it in 1 quarter. The position peaked at $1.38M in Q4 2021. 728 funds tracked by Wall St. Rank hold VOT as of Q1 2022.

  • Acute Investment Advisory reported no remaining Vanguard Mid-Cap Growth ETF position as of Q1 2022 after selling out during the quarter.
  • Acute Investment Advisory sold 5,437 Vanguard Mid-Cap Growth ETF shares in Q1 2022, an estimated $1.38M.
  • Acute Investment Advisory first reported a position in Vanguard Mid-Cap Growth ETF in Q4 2021 and held it in 1 quarter.
  • Acute Investment Advisory's Vanguard Mid-Cap Growth ETF position peaked at $1.38M in Q4 2021.
  • 728 funds tracked by Wall St. Rank held Vanguard Mid-Cap Growth ETF as of Q1 2022.

Based on Acute Investment Advisory's 13F filing for Q1 2022, filed 31 Aug 2022.